Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II
NCT06882499 · NOT YET RECRUITING · N/A
We track 2 ClinicalTrials.gov studies led by Peter Maccallum Cancer Centre Australia. The portfolio skews toward N/A (2 trials).
2 clinical trials sponsored by Peter Maccallum Cancer Centre Australia.
| Phase | Trials | Distribution |
|---|---|---|
| N/A | 2 | 100% |
Peter Maccallum Cancer Centre Australia currently sponsors 2 clinical trials tracked on ReadTheTrial. These span N/A.
Peter Maccallum Cancer Centre Australia conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.